2020: 7th Outstanding Youth Science and Technology Innovation Talent, Shanghai Branch of Chinese Academy of Sciences
2020: WuXi AppTec Life Chemistry Research Award
2019: 4th Zhongyuan Concord Life Medicine Innovation Breakthrough Award
2018: Leading Talent in Science and Technology Innovation, Ministry of Science and Technology
2013: Excellent Young Scholar Award, 8th China Human Proteome Conference
Research
Proteomics Post-translational Modifications Biomass Spectrometry Precision Medicine
DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser56 to diminish pancreatic β cell function upon overnutrition., Lu Y, Xu J, Li Y, Wang R, Dai C, Zhang B, Zhang X, Xu L, Tao Y, Han M, Guo R, Wu Q, Wu L*, Meng Z*, Tan M*, Li J*., 2024
Spatiotemporal and direct capturing global substrates of lysine-modifying enzymes in living cells., Hu H, Hu W, Guo AD, Zhai L, Ma S, Nie HJ, Zhou BS, Liu T, Jia X, Liu X, Yao X, Tan M*, Chen X*., 2024
Spatiotemporal and global profiling of DNA-protein interactions enables discovery of low-affinity transcription factors., Guo A, Yan K, Hu, H, Zhai L, Hu T, Su,H, Chi Y, Zha,J, Xu Y, Zhao,Y Lu X, Xu Y, Zhang J, Tan M*, Chen X*., 2023
ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA- Encoded Libraries., Jiang L, Liu S, Jia X, Gong Q, Wen X, Lu W, Yang J, Wu X, Wang X, Suo Y, Li Y, Uesugi M, Qu ZB, Tan M,* Lu X,* Zhou L.*, 2023
Energy sensor AMPK gamma regulates translation via phosphatase PPP6C independent of AMPK alpha., Zhou Q, Hao B, Cao X, Gao L, Yu Z, Zhao Y, Zhu M, Zhong G, Chi F, Dai X, Mao J, Zhu Y, Rong P, Chen L, Bai X, Ye C, Chen S, Liang T, Li L, Feng XH*, Tan M*, Zhao B*., 2022
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies., Liu Z, Liu Y, Qian L, Jiang S, Gai X, Ye S, Chen Y, Wang X, Zhai L, Xu J, Pu C, Li J, He F, Huang M*, and Tan M*., 2021
DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing., Li Y, Xu J, Lu Y, Bian H, Yang L, Wu H, Zhang X, Zhang B, Xiong M, Chang Y, Tang J, Yang F, Zhao L, Li J, Gao X, Xia M*, Tan M*, Li J*., 2021
Integrative proteomic characterization of human lung adenocarcinoma., Xu J, Zhang C, Wang X, Zhai L, Ma Y, Mao Y, Qian K, Sun C, Liu Z, Jiang S, Wang M, Feng L, Zhao L, Liu P, Wang B, Zhao X, Xie H, Yang X, Zhao L, Chang Y, Jia J, Wang X, Zhang Y, Wang Y, Yang Y, Wu Z, Yang L, Liu B, Zhao T, Ren S, Sun A, Zhao Y, Ying W, Wang F, Wang G, Zhang Y, Cheng S, Qin J, Qian X, Wang Y*, Li J*, He F*, Xiao T*, Tan M*., 2020
Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors., Huang X, Yan J, Zhang M, Wang Y, Chen Y, Fu X, Wei R, Zheng XL, Liu Z, Zhang X, Yang H, Hao B, Shen YY, Su Y, Cong X, Huang M, Tan M*, Ding J*, Geng M*., 2018
Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis., Liu B, Jiang S, Li M, Xiong X, Zhu M, Li D, Zhao L, Qian L, Zhai L, Li J, Lu H, Sun S, Lin J, Lu Y *, Li X*, Tan M*., 2018
Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification., Tan M.#, Luo H.#, Lee S.#, Jin F., Yang J.S., Montellier E., Buchou T., Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J., Ye Y., Khochbin S., Ren B., Zhao Y*., 2011
Identification of lysine succinylation as a new post-translational modification., Zhang, Z.#, Tan, M.#, Xie, Z., Dai, L., Chen, Y., Zhao, Y*., 2011
